Larimar Therapeutics
LRMR
LRMR
45 hedge funds and large institutions have $143M invested in Larimar Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
31% less capital invested
Capital invested by funds: $206M → $143M (-$63.3M)
40% less call options, than puts
Call options by funds: $6K | Put options by funds: $10K
60% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 20
Holders
45
Holding in Top 10
2
Calls
$6K
Puts
$10K
Top Buyers
| 1 | +$7.15M | |
| 2 | +$6.73M | |
| 3 | +$4.49M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.85M |
Top Sellers
| 1 | -$9.02M | |
| 2 | -$3.66M | |
| 3 | -$3.36M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$3.2M |
| 5 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.8M |